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The Role of Smads in Skin Development
Philip Owens1,2,3, Gangwen Han1,2,3, Allen G. Li1,2,3 and Xiao-Jing Wang1,2,3
Smads are a group of signaling mediators and antagonists of the transforming growth factor-b (TGF-b)
superfamily, responding but not limited to signaling from TGF-b, Activin, and bone morphogenetic proteins
(BMPs). As all of these three signaling pathways play important roles in skin development, we have been actively
pursuing studies assessing the role of Smads in skin development. Our studies revealed that Smad-4 affects hair
follicle differentiation primarily by mediating BMP signaling. Smad-7 significantly affects hair follicle
development and differentiation by blocking the TGFb/Activin/BMP pathway and by inhibiting WNT/b-catenin
signaling via ubiquitin-mediated b-catenin degradation. In contrast, other Smads may have redundant or
dispensable functions in skin development. Here, we review the work that shows the emergence of Smad
functions in skin development via traditional and novel signaling pathways.
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Introduction
Smads are intracellular proteins that
shuttle from the cytoplasm to the
nucleus. There are three classes of
Smad proteins termed receptor-specific
Smads (R-Smad – 1–3, 5, and 8),
inhibitory Smads (I-Smad – 6 and 7),
and the common partner or mediator
Smad (Smad-4) (ten Dijke and Hill,
2004; Massague et al., 2005). R-Smads
are phosphorylated by the serine/threo-
nine kinase domain of the transforming
growth factor-b (TGF-b) family recep-
tors, once these receptors are activated
by their ligands (Figure 1). Phosphory-
lated R-Smads then bind with Smad-4
and enter the nucleus, where the Smad
complex transcriptionally regulates
gene expression by binding sequence-
specific elements within the promoters
of target genes termed ‘‘Smad binding
elements.’’ The Smad complex at the
Smad binding elements requires re-
cruits co-factors to elicit a myriad of
transcriptional responses including ac-
tivation or repression. Among R-Smads,
Smad-2 and -3 are regulated by TGF-b
and Activin, whereas Smad-1, -5, and -
8 are primarily activated by bone
morphogenetic proteins (BMPs). The
I-Smads block the ability of their
respective receptors to phosphorylate
R-Smads. Smad-6 preferentially antag-
onizes the signaling of Smad-1, -5,
and -8, whereas Smad-7 preferentially
antagonizes the signaling of Smad-2
and -3.
The mammalian epidermis and its
appendages develop from a simple
ectoderm to a stratified epithelium
during embryogenesis. In mice, epider-
mal development begins at embryonic
day 9.5 (E9.5). Upon birth, the epider-
mis is fully differentiated, expressing
differentiation markers for the termin-
ally differentiated epidermis (Fuchs and
Raghavan, 2002). Epidermal appen-
dages consist of hair follicles, sebac-
eous/sweat glands, mammary glands,
teeth, nails/claws, as well as parts of
the external genitalia structure. Of
these appendages, the best studied
and understood is the hair follicle.
The primary murine hair follicle, which
gives rise to the guard hair, begins to
develop at E14.5. Secondary hair folli-
cles (awl and zigzag) begin to develop
approximately 2 days later and make
up the majority of hair follicles in
mouse skin. When hair follicles deve-
lop, epidermal keratinocytes receive
instructive signals from the underlying
mesenchyme (dermis), and then aggre-
gate and form a condensation (pla-
code). The placodes then become
associated with underlying dermal con-
densates and give rise to the hair germ.
As hair follicles move downwards, the
dermal condensates are engulfed by the
broadened bottom of downgrowing
hair follicles (hair pegs), forming der-
mal papillae. The instructive signals for
hair follicle morphogenesis are from
but not limited to the pathways of
WNT/b-catenin, Hedgehog, fibroblast
growth factor (FGF) and BMP. Once the
hair follicles have been specified, they
grow until approximately two weeks
postnatally and begin their cycling.
Hair cycling begins with the catagen
or regressing phase. Once they are
physically separated from the dermal
papillae, the hair follicles enter into the
telogen or resting phase. The transition
from telogen to the anagen or regrowth
phase utilizes the molecular mechan-
isms involved in hair follicle induction
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during embryonic hair development.
Sebaceous glands develop in the first
week after birth and alter their size
proportionally with the associated hair
follicles during hair cycling. Under-
neath the sebaceous glands, the size of
the ‘bulge’ region remains persistent
throughout the hair cycle, which has
been widely characterized as a region
of multipotent stem cells Blanpain and
Fuchs, 2006; Moore and Lemischka,
2006). Delicate machinery that regu-
lates stem cell fate and progenitor
differentiation is thus required for
proper skin development during em-
bryonic stages and for the maintenance
of tissue homeostasis. Recent studies
have shown that expression of Smads
and their target genes are enriched in
the epidermal stem cell population
(Morris, 2004; Tumbar et al., 2004).
The contribution of the TGF-b super-
family to epidermal development
TGF-b and Activin ligands activate
Smad-2 and -3 via the type I receptors
activin-like kinase (Alk)-1, -4, -5, and
-7. Among the three TGF-b isoforms,
TGF-b2 is both required and sufficient
to induce hair follicles in mice (Foitzik
et al., 1999), via a mechanism of RAS/
mitogen-activated protein kinase acti-
vation and subsequent transcription of
Snail (Jamora et al., 2005). Although
neither TGF-b1 nor TGF-b3 is required
for hair follicle development, TGF-b1 is
a potent inducer of catagen (Foitzik
et al., 2000), and TGF-b3 has been
shown to regulate keratinocyte migra-
tion during wound healing (Bandyo-
padhyay et al., 2006). In addition to
TGF-b ligands, Activin exerts an effect
on skin development. Mice lacking
activin-bA lack vibrissae and vibrissae
follicles (Matzuk et al., 1995a). Germ-
line deletion of follistatin, an Activin-
binding protein and antagonist, results
in a hyperkeratotic epidermis and
abnormal vibrissae that appear thin
and inappropriately orientated (Matzuk
et al., 1995b). Correspondingly, follis-
tatin knockout mice and Activin-bA
transgenic mice show a delay of hair
follicle morphogenesis. Treatment of
wild-type embryonic skin explants with
follistatin protein stimulated hair folli-
cle development. This effect can be
attenuated by Activin A. Activin-bA
transgenic mice demonstrate a failure
of catagen entry (Nakamura et al.,
2003). These findings highlight the
important signaling and crosstalk from
mesenchymal cells of the dermal pa-
pillae to differentiated keratinocytes of
the hair follicle. Presumably, these
ligands and antagonists coordinate
their function via Smad activation.
BMPs comprise a large group of
soluble proteins that activate Smad-1,
-5, and -8 via the type I receptors ALK-2,
-3, and -6. It has been difficult to study
the requirement for BMP signaling in
epidermal development because differ-
ent BMP ligands and receptors are
expressed in different epithelial and
stromal compartments or in cells of
different lineages within the same com-
partment. Advances in understanding
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Figure 1. Smad signaling. Smads are intracellular signaling molecules that are phosphorylated by the serine/threonine kinase receptors of transforming growth
factor-b (TGF-b)/Activin or bone morphogenetic protein (BMP). These receptors are activated (phosphorylated) upon ligand binding to their extracellular
domains. Once phosphorylated, receptor-specific Smads (R-Smads) then partner with Smad-4 where they form a hetero–trimeric complex and shuttle into the
nucleus. Upon entry to the nucleus, Smads form diverse associations with transcription co-factors and bind site-specific Smad binding elements (SBE). Smad-2
and -3 (Smad-2/3) are signaled from TGF-b/Activin ligands, whereas Smad-1, -5, and -8 (Smad-1/5/8) are activated from BMP ligands. For each R-Smad group,
there lies an inhibitory Smad (I-Smad): Smad-6 preferentially inhibits Smad-1/5/8 and Smad-7 preferentially inhibits Smad-2/3.
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BMP functions in the skin have mainly
come from keratinocyte-specific BMP
transgenic mouse models (Botchkarev
and Sharov, 2004). A recent study
shows that BMP-2 induces transcription
of canonical WNT/b-catenin family
ligands and receptors to regulate cell
fate in human keratinocytes (Yang
et al., 2006). Many BMP ligands and
their antagonists do not determine
specific cell fate but help to regulate
the proper timing and behavior of a
specific cell lineage. For instance,
administration of Noggin protein into
telogen mouse skin revealed that Nog-
gin is required for postnatal hair follicle
cycling (Botchkarev et al., 2001). The
mechanism of Noggin-induced hair
follicle re-growth is associated with
attenuating the inhibitory effect of
BMP-4 on Sonic Hedgehog (Shh) ex-
pression. A recent study demonstrates
that mice overexpressing Noggin using
a keratin 5 promoter increased cell
proliferation via affecting genes con-
trolling cell-cycle progression (Sharov
et al., 2006). In contrast, when primary
keratinocyte explants were treated with
BMPs, they became quiescent and
underwent growth arrest (Sharov
et al., 2006). A study from Elaine Fuchs’
laboratory provided further evidence
for the involvement of BMP in skin
development by showing that BMP-6 is
expressed in the dermal papillae and
the stem cell niche (Fuchs et al., 2004).
This finding suggests that BMP-6 is a
potent inducer of matrix cells in the
developing hair follicle. The BMP
antagonist Cripto was also upregulated
in isolated and enriched epidermal
stem cells, the function of which
remains to be determined (Fuchs
et al., 2004). Several studies have
provided evidence for the requirement
of ALK-3 (bone morphogenetic protein
receptor 1A) in postnatal hair follicle
maintenance. In these studies, ALK-3
was conditionally deleted in keratino-
cytes, which resulted in the collapse of
the hair follicles postnatally (Kobielak
et al., 2003; Andl et al., 2004; Ming
Kwan et al., 2004; Yuhki et al., 2004).
These reports demonstrated that ALK-3
is required for the formation of the
differentiated matrix cells of the hair
follicle. More recently, a study has
shown that deletion of ALK-3 in the
hair follicle lead to an increased
population of hair follicle stem cells,
which fail to utilize b-catenin to specify
hair follicle lineages. In contrast, acti-
vation of Akt and loss of PTEN (phos-
phatase and Tensin homolog) were
found in these stem cells (Zhang
et al., 2006). This report suggested that
ALK-3 functions to define the progeny
of the hair follicle stem cell niche and
regulate a discrete balance of com-
mitted and undifferentiated cells
(Zhang et al., 2006). It remains to be
determined if the effects of these BMP
ligands and receptors require spatio-
temporal Smad activation.
R-Smads: little effect on skin develop-
ment
Even though TGF-b superfamily mem-
bers and receptors exert profound
effects on skin development and there
is abundant expression of Smads 1–5 in
the epidermis and hair follicles (He
et al., 2001), studies have revealed little
effect of individual R-Smads on skin
development and differentiation.
Germline Smad-2 knockout mice die
at the embryonic stage before hair
follicle development due to failure of
germ layer specification and primitive
streak formation (Waldrip et al., 1998).
Transgenic mice overexpressing Smad-
2 using the keratin 14 promoter exhibit
delayed hair growth, underdeveloped
ears, and shortened tails. Further ana-
lysis suggests that these phenotypes
correlated with enhanced signaling
from TGF-b and Activin (Ito et al.,
2001). It remains to be determined if
there are any pathological conditions
in which Smad-2 is overexpressed in
the skin. At the physiological level,
Smad-2 alone appears to have little
effect on skin development, as our
unpublished data reveal that keratino-
cyte-specific Smad-2 deletion did not
result in obvious abnormalities in skin
development. Similarly, Smad-3 knock-
out mice have no apparent phenotype
related to aberrant epidermal develop-
ment. With respect to Smad-1, -5, and
-8, very little is known about the
individual roles of these Smads in the
epidermis. Antibody staining, which
recognizes all three phosphorylated
form, thereby serving as a readout
of BMP activity, revealed abundant
phospho-Smad-1/5/8 staining in both
interfollicular epidermis and hair folli-
cles (Han et al., 2006). Some links for
the involvement of these Smads in skin
development and differentiation has
been suggested by studies of Smad co-
factors and target genes. For instance,
Smad-1 and -4 form a transcriptional
complex on the promoter of the Dlx3
transcription factor (Park and Morasso,
2002). Dlx3 is a homeodomain tran-
scription factor that helps pattern and
specify cell fate in keratinocytes and its
expression is induced by BMP-2 (Park
and Morasso, 2002). Another potential
link to Smad-1/5/8 may be RUNX3, a
transcription factor often demonstrated
to partner with Smad-1/5/8 during
osteoblast formation. Runx3 was found
to be a critical determinant of hair
shape as well as nail and gland forma-
tion (Raveh et al., 2005). However,
direct evidence for BMP-specific
Smads in skin development is lacking.
Our unpublished data revealed that
keratinocyte-specific deletion of either
Smad-1 or -5 did not affect skin
development and differentiation. To
date, there is no report for Smad-8
function in the epidermis. Because of
the structural similarity and the lack of
antibodies specific for individual BMP-
specific Smads, it is difficult to deter-
mine if they have redundant functions
in the skin.
Smad-4: the bridge between R-Smads
The lack of skin phenotypes in R-Smad
knockout keratinocytes suggests that
individual Smads may compensate for
each other’s loss during skin develop-
ment and differentiation. Indeed, when
Smad-4 is deleted in keratinocytes,
which results in abrogation of most
Smad signaling, hair follicles collapse
(Yang et al., 2005; Qiao et al., 2006).
These mice lost postnatal hair follicles
before the first catagen entry. Sponta-
neous squamous cell carcinomas were
also identified. Interestingly, the phe-
notypes of Smad4/ hair follicles were
very similar to those in epidermal-
specific ALK-3 knockout mice (Kobie-
lak et al., 2003; Andl et al., 2004; Ming
Kwan et al., 2004; Yuhki et al., 2004),
which illustrates a possible depen-
dence of Smad-4 on BMP signaling
but not on Activin or TGF-b signaling
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(Figure 1). Smad-4 has been identified
to partner with Lef1 at the Msx2
promoter (Hussein et al., 2003), repre-
senting a significant link to the WNT/b-
catenin signaling cascade, which is
critical for hair development and differ-
entiation. Therefore, Smad-4 may co-
operate with WNT/b-catenin signaling
at the transcriptional level. Another
transcriptional partner of Smads shown
in T cells is GATA-3 (Blokzijl et al.,
2002). In the skin, GATA-3 is expressed
specifically in the inner root sheath
(IRS) (Kaufman et al., 2003). Mice with
a GATA-3 gene deletion exhibited a
collapsed hair follicle phenotype (Kauf-
man et al., 2003) similar to the
keratinocyte-specific Smad-4 knockout
hair follicles. It remains to be deter-
mined if GATA-3 and Smads form a
functional transcription complex that
specifies the differentiated IRS of the
hair follicle. Another interesting Smad
partner may be FOXO factors, which,
like Smads, are proteins that shuttle
between the nucleus and cytoplasm
and are found to be expressed in
human keratinocytes (Gomis et al.,
2006). FOXO transcription factors be-
long to the winged helix domain of
transcription factors, which is a large
family that also includes FoxN1, a
transcription factor responsible for the
nude mouse phenotype (Mecklenburg
et al., 2001). It remains to be deter-
mined if FoxN1 has a direct interaction
with Smads, similar to what has
been demonstrated with FOXO family
members.
Smad-4 has been considered neces-
sary for Smad signaling because it was
widely required for many Smad-asso-
ciated processes. This notion has been
challenged by the observation that
when Smad-4 is inhibited in HaCaT
keratinocytes, R-Smad transcriptional
activity still occurred (Levy and Hill,
2005). Further evidence from the he-
matopoietic system has shown that
Smad-4 loss results in new stoichio-
metric accumulations of R-Smads with
the TIF1-g transcription factor (He
et al., 2006). TIF1-g is exclusively
nuclear and does not aid in the
shuttling of Smad-2/3 into the nucleus.
This study shows that even when Smad-
4 is removed, phosphorylated R-Smad
complexes may still bind their target
genes. For the above reasons, it is not
surprising that epidermal and hair
follicle development is largely intact
when Smad-4 is deleted in keratino-
cytes. However, regardless of the initial
normal embryonic skin development,
homeostasis in Smad4-deleted kerati-
nocytes apparently is lost, which even-
tually results in skin tumor formation.
I-Smads: restricting and refining R-Smads
Within the two I-Smads, abundant
Smad-6 mRNA was detected in the
developing mouse skin at E15 (Flanders
et al., 2001). This report also identified
that the vibrissae follicles lack Smad-6
expression. There have been reports of
transient expression or loss of expres-
sion of Smad-6 in early mouse devel-
opment and in pathological conditions.
For instance, Smad-6 and -7 are lost in
keloids, which are benign tumors in the
skin that result from overaccumulation
of extracellular matrix proteins as a
result of un-inhibited TGF-b signaling
(Yu et al., 2006). Further studies on
Smad-6 functioning in skin pathology
remain to be done. Almost little or no
expression of Smad-6 is detected in the
adult skin (He et al., 2002). However,
the role of Smad-6 in the skin is
basically unknown. A thorough exam-
ination of Smad-6 expression patterns
during different developmental stages
and physiological/pathological states of
the skin will serve as an initial step
toward identifying which, if any, role of
Smad-6 in the skin.
To date, Smad-7 has shown the most
effects among all Smads on skin devel-
opment. Smad-7 is expressed at a very
low level in normal keratinocytes (He
et al., 2001), but is often overexpressed
under pathological conditions, for ex-
ample, in intrinsically aged and photo-
aged human skin (He et al., 2002;
Quan et al., 2002) and during skin
carcinogenesis (He et al., 2001). To
access the overall role of Smad signal-
ing in skin development, we generated
Smad-7 transgenic mice, which over-
express Smad-7 under the control of a
keratin 5 promoter (K5.Smad-7) to
levels that are sufficient to block Smad
signaling from TGF-b/Activin and BMP
(He et al., 2002). These transgenic mice
exhibit multiple developmental defects
in the stratified epithelia, including
decreased hair follicle size. They die
perinatally due to epithelial hyperker-
atosis in the upper digestive tract and
severe thymic atrophy (He et al., 2002).
Since the phenotype severity correlates
with the degree of Smad signaling
inhibition, these data suggest the im-
portance of Smad signaling in skin
development, which would not neces-
sarily be revealed in individual Smad
knockout skin if the Smads have func-
tional redundancy. However, one
K5.Smad-7 transgenic line, which ex-
pressed a low level of Smad-7 trans-
gene, and therefore did not block Smad
signaling, still exhibited a hair loss
phenotype (Han et al., 2006).
To understand further the mechan-
ism, we generated Smad-7 transgenic
mice, in which the Smad-7 transgene
can be induced in keratinocytes at
different developmental stages and at
different levels in keratinocytes includ-
ing epidermal stem cells. This induci-
ble transgenic system consists of a
transactivator line (GLp65) (Cao et al.,
2002; Lu et al., 2004) and a target line
(tata.Smad-7). The keratin 5 vector was
used to target the GLp65 transactivator
to the basal layer of the epidermis and
the outer root sheath of the hair follicle,
including epidermal stem cells (Arin
et al., 2001). The target transgene
(tata.Smad-7) consists of a GAL4 UAS
enhancer upstream of a tata minimal
promoter (Cao et al., 2002; Lu et al.,
2004) and cDNA encoding mouse
Smad-7 with a Flag tag (He et al.,
2002). RU486 is used to regulate
transgene expression in bigenic mice
(GLp65/tata.Smad-7). The ability to
control Smad-7 expression at a patho-
logically relevant level and in an acute
or a sustained manner furthered our
analysis of the underlying molecular
mechanisms. This model has also
helped us to determine the role of
Smad-7 overexpression at stages criti-
cal for stem cell fate decision and
differentiation as well as in postnatal
hair cycling. We found that Smad-7
transgene induction resulted in a sig-
nificant delay in embryonic hair follicle
development and a complete blockade
of hair follicle differentiation (Figure 2).
When transgenic Smad-7 expression
was induced in a sustained manner
beginning either on E10.5 or on E14.5,
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the effect on bigenic mouse skin from
E16.5 throughout P1 was essentially
identical. In both cases, histological
examination showed that hair follicle
morphogenesis was delayed in Smad-7
transgenic skin in comparison with
normal skin. On E16.5, hair follicles
in normal embryos are in developmen-
tal stage 2 or 3, in which follicles
appear to be in the form of a hair germ
or peg, respectively. In contrast, only
scattered hair follicle placodes were
observed in Smad-7 transgenic em-
bryos. On E18.5, certain follicles in
control skin have entered stage 4,
characterized by the beginning of IRS
formation and engulfment of dermal
papilla within the hair bulb. In contrast,
Smad-7 E18.5 hair follicles were in
stages 1 and 2. In P1 normal skins,
more than 50% of the hair follicles
have passed stage 4, and some have
entered stage 5, evidenced by the
presence of melanin in the precortex
and an elongated IRS. However, the
majority of the hair follicles in P1
Smad-7 transgenic skin were in stages
2 and 3, equivalent in appearance to
the E16.5 normal embryonic hair folli-
cles. After birth, if Smad-7 transgene
induction was continuously main-
tained, hair follicle differentiation was
abrogated. At P10, normal skin hair
follicles have each formed a well-
differentiated hair shaft. However,
Smad-7 transgenic follicles were much
shorter and disoriented with prominent
sebaceous glands and clustered mela-
nin. Hair follicle differentiation mar-
kers, the AE15 antibody stained IRS
cells and medulla cells of the hair shaft
and the AE13 antibody stained upper
cortical and cuticle cells, are absence
in Smad-7 transgenic hair follicles that
appeared disorganized and lacked any
obvious IRS or hair shaft. In contrast,
sebaceous gland development was sig-
nificantly accelerated in Smad-7 trans-
genic skin (Figure 3). Sebocytes are
visible on P1 Smad-7 transgenic skin,
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Figure 2. Smad-7 induction perturbed hair follicle development and differentiation. (a) Hematoxylin
and eosin staining of embryonic E16.5, E18.5, and P1 skin that was exposed to daily RU486 treatment
in utero beginning on E14.5. Arrows point to representative hair follicles in different developmental stages
(S). Note that the epidermis of E18.5 and P1 transgenic skin also exhibited mild hyperplasia. The bar in
the first panel represents 50 mm for all sections in (a). The AE15 antibody stained the inner root sheath
(IRS) cells and medulla cells of the hair shaft and the AE13 antibody stained upper cortical and cuticle
cells. (b) Histology and immunostaining using AE13 and AE15 antibodies on P10 control and Smad-7
transgenic skins. In hematoxylin and eosin sections (left), arrows in Smad-7 transgenic skin point to the
sebaceous glands. In immunostaining panels (middle and right), arrows in control skin point out
examples of normal staining patterns. Note that arrows in Smad-7 transgenic skin point out aberrant
staining patterns. Dark staining in Smad-7 transgenic follicles represents irregular melanin deposits. The
bar in the first panel represents 50 mm for all sections in (b). This is supplemental Figure 2 in Han et al.,
Dev Cell, 11:301–312, 2006.
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Figure 3. Smad-7 induction accelerates sebaceous gland morphogenesis. Oil-red-O staining was used to detect sebocytes. Hematoxylin was used as a counter
stain. Note that sebaceous glands, hair canal, and subcutaneous fat tissue are positively stained by Oil-red-O. Arrows denote representative sebocytes or
sebaceous glands. The bar in the first panel represents 100 mm for all sections.
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but not on control skin. Again, when
the Smad-7 transgene is expressed at
levels high enough to inhibit Smad
signaling, these skin phenotypes are
exacerbated and epidermal differentia-
tion is also perturbed. However, even
when Smad-7 is expressed at a lower
level that does not affect Smad signal-
ing, these skin abnormalities still occur.
Further analysis revealed that inde-
pendent of its role in anti-Smad signal-
ing, Smad7-bound b-catenin and
induced b-catenin degradation by re-
cruiting an E3 ligase, Smurf2 to the
Smad-7/b-catenin complex. Conse-
quently, WNT/b-catenin signaling was
suppressed in Smad-7 transgenic hair
follicles. Co-expression of Smurf2 and
Smad-7 transgenes exacerbated
Smad7-induced abnormalities in hair
follicles and sebaceous glands. Con-
versely, when endogenous Smad-7 was
knocked down, keratinocytes exhibited
increased b-catenin protein and en-
hanced WNT signaling. These data
suggest that even at a low, physiologi-
cal level, endogenous Smad-7 partici-
pates in b-catenin turnover (Figure 4).
This mechanism also explains the
phenotype difference between Smad4/
skin and Smad-7 transgenic skin, which
cannot be explained by the difference
in the degree of abrogating Smad
signaling. Although Smad-4 also poten-
tially affects WNT/b-catenin signaling
at the transcriptional level, the direct
effect of Smad-7 on b-catenin degrada-
tion appears to be more potent in
affecting WNT/b-catenin signaling.
This is probably why Smad-7 trans-
genic, but not Smad4 null skin, exhibits
delayed hair follicle development.
Cytoplasm
LEF/TCF response element
Smad7
Smad7
Smad7
R-Smads
Nucleus
RI
RII
P
a
Cytoplasm
Nucleus
b
Wnts
Frizzled
receptor
Wnts
Frizzled 
receptor
LEF/TCF
26S Proteasome
LEF/TCF
Smurf2
Ub
Ub
Ub
P
P
P
TGF /activin/ 
BMP
 -Cat
 -
Ca
t
LEF/TCF response element
 -Cat
 -Cat
 -
Ca
t
Figure 4. Antagonizing Smad signaling and Wnt signaling by Smad-7. (a) Smad-7 inhibits phosphorylation and receptor Smad complex assembly to restrict
and terminate signaling from transforming growth factor b (TGFb)/activin or bone morphogenetic protein (BMP). If WNT (wingless related) signaling is
unaffected by Smad-7, WNT ligands bind cognate frizzled receptors, resulting in releasing of b-catenin (b-cat) from the membrane and sent to the nucleus
to induce transcription of targets with LEF/TCF (lymphoid enhancement factor/T-cell factor) transcriptional partners. (b) Smad-7 recruits the ubiquitin E3
ligase Smurf2 to b-catenin in the cytoplasm to induce b-catenin degradation. b-Catenin is degraded in the 26S proteasome. This activity of Smad-7 inhibits
WNT signaling by preventing b-catenin entering into the nucleus.
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Conclusions and future perspectives
To date, the most significant advances
in our understanding of Smad functions
in the skin have come from mouse
models with spatio-temporal expres-
sion/ablation of individual Smad genes.
Among them, only Smad-4 loss or
Smad-7 overexpression in keratino-
cytes results in abnormalities of epider-
mal and hair follicle development and/
or differentiation (Figure 5). In the
future, thorough examination of Smad
expression patterns at specific develop-
mental stages and pathological condi-
tions of the skin (e.g., wound healing,
cancer, and various skin diseases) will
provide valuable lessons for Smad
function in the epidermis. More com-
plex genetic approaches such as knock-
ing out more than one Smad gene at a
time in keratinocytes and combination
of these knockouts with transgenics
overexpressing TGF-b family ligands
will further elucidate the overlapping
and compensatory functions of indivi-
dual Smads in the skin. The recent
finding that Smad-7 functions in the
WNT/b-catenin pathway demonstrates
that Smad proteins are not simply
mediators/antagonists of TGF-b signal-
ing. It remains to be determined how
other pathways are integrated by
Smads and under what physiological/
pathological conditions these interac-
tions occur.
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